Back to Journals » Neuropsychiatric Disease and Treatment » Volume 12

Neuropsychiatric Disease and Treatment


Archive: Volume 12, 2016

Association between the high-dose use of benzodiazepines and rehospitalization in patients with schizophrenia: a 2-year naturalistic study

Takita Y, Takaesu Y, Ono K, Futenma K, Shimura A, Murakoshi A, Komada Y, Inoue Y, Inoue T

Neuropsychiatric Disease and Treatment 2016, 12:3243-3247

Published Date: 15 December 2016

Impact of parental presence during induction of anesthesia on anxiety level among pediatric patients and their parents: a randomized clinical trial

Sadeghi A, Khaleghnejad Tabari A, Mahdavi A, Salarian S, Razavi SS

Neuropsychiatric Disease and Treatment 2016, 12:3237-3241

Published Date: 20 February 2017

Non-24-hour sleep–wake syndrome improved by low-dose valproic acid: a case report

Kurita M, Moriya T, Nishino S, Hirata E, Hirasawa N, Okubo Y, Sato T

Neuropsychiatric Disease and Treatment 2016, 12:3199-3203

Published Date: 13 December 2016

Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities

Okazaki K, Makinodan M, Yamamuro K, Takata T, Kishimoto T

Neuropsychiatric Disease and Treatment 2016, 12:3195-3198

Published Date: 14 December 2016

Neuroprotection and acidosis induced by cortical spreading depression

Kwong KK, Chan ST

Neuropsychiatric Disease and Treatment 2016, 12:3191-3194

Published Date: 12 December 2016

Associations between the mismatch-negativity component and symptom severity in children and adolescents with attention deficit/hyperactivity disorder

Yamamuro K, Ota T, Iida J, Nakanishi Y, Kishimoto N, Kishimoto T

Neuropsychiatric Disease and Treatment 2016, 12:3183-3190

Published Date: 12 December 2016

The impact of residual symptoms on relapse and quality of life among Thai depressive patients

Hiranyatheb T, Nakawiro D, Wongpakaran T, Wongpakaran N, Bookkamana P, Pinyopornpanish M, Saisavoey N, Wannarit K, Satthapisit S, Tanchakvaranont S

Neuropsychiatric Disease and Treatment 2016, 12:3175-3181

Published Date: 12 December 2016

Treadmill exercise promotes neuroprotection against cerebral ischemia–reperfusion injury via downregulation of pro-inflammatory mediators

Zhang Y, Cao RY, Jia X, Li Q, Qiao L, Yan G, Yang J

Neuropsychiatric Disease and Treatment 2016, 12:3161-3173

Published Date: 12 December 2016

Effect of dexmedetomidine on hippocampal neuron development and BDNF-TrkB signal expression in neonatal rats

Lv J, Ou W, Zou XH, Yao Y, Wu JL

Neuropsychiatric Disease and Treatment 2016, 12:3153-3159

Published Date: 9 December 2016

Baicalein improves behavioral dysfunction induced by Alzheimer’s disease in rats

Zhou L, Tan S, Shan YL, Wang YG, Cai W, Huang XH, Liao XY, Li HY, Zhang L, Zhang BJ, Lu ZQ

Neuropsychiatric Disease and Treatment 2016, 12:3145-3152

Published Date: 9 December 2016

Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis

He HR, Wu HH, Yang LH, Gao F, Fan YJ, Feng JQ, Ma XC

Neuropsychiatric Disease and Treatment 2016, 12:3129-3144

Published Date: 9 December 2016

Diminished autonomic neurocardiac function in patients with generalized anxiety disorder

Kim K, Lee S, Kim JH

Neuropsychiatric Disease and Treatment 2016, 12:3111-3118

Published Date: 8 December 2016

Age-related issues of instruments screening for autism in young children

Thomaidis L, Choleva A, Kyprianou M

Neuropsychiatric Disease and Treatment 2016, 12:3093-3095

Published Date: 5 December 2016

miR-455 inhibits neuronal cell death by targeting TRAF3 in cerebral ischemic stroke

Yao ST, Tang B, Li G, Fan RM, Cao F

Neuropsychiatric Disease and Treatment 2016, 12:3083-3092

Published Date: 5 December 2016

Global economic burden of schizophrenia: letter in response

Neil AL, Carr VJ

Neuropsychiatric Disease and Treatment 2016, 12:3069-3072

Published Date: 5 December 2016

A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders

Kishi T, Matsuda Y, Matsunaga S, Mukai T, Moriwaki M, Tabuse H, Fujita K, Iwata N

Neuropsychiatric Disease and Treatment 2016, 12:3041-3049

Published Date: 28 November 2016

Functional cortical changes in relapsing-remitting multiple sclerosis at amplitude configuration: a resting-state fMRI study

Liu H, Chen H, Wu B, Zhang TJ, Wang J, Huang KX, Song GJ, Zhan J

Neuropsychiatric Disease and Treatment 2016, 12:3031-3039

Published Date: 25 November 2016

Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders – a cross-sectional study

Holubova M, Prasko J, Matousek S, Latalova K, Marackova M, Vrbova K, Grambal A, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:3021-3030

Published Date: 24 November 2016

Self-stigma and schizophrenia: a cross-sectional study

Vrbova K, Prasko J, Holubova M, Kamaradova D, Ociskova M, Marackova M, Latalova K, Grambal A, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:3011-3020

Published Date: 24 November 2016

Factors related to depression and anxiety in adults with bronchiectasis

Özgün Niksarlioglu EY, Özkan G, Günlüoglu G, Uysal MA, Gül S, Kilic L, Yeter A, Çamsari G

Neuropsychiatric Disease and Treatment 2016, 12:3005-3010

Published Date: 23 November 2016

Evaluation of novel candidate variations and their interactions related to bipolar disorders: Analysis of GWAS data

Acikel C, Aydin Son Y, Celik C, Gul H

Neuropsychiatric Disease and Treatment 2016, 12:2997-3004

Published Date: 24 November 2016

Perceptions and impact of bipolar disorder in Japan: results of an Internet survey

Watanabe K, Harada E, Inoue T, Tanji Y, Kikuchi T

Neuropsychiatric Disease and Treatment 2016, 12:2981-2987

Published Date: 21 November 2016

Factors associated with vitamin D status of low-income, hospitalized psychiatric patients: results of a retrospective study

Bazzano AN, Littrell L, Lambert S, Roi C

Neuropsychiatric Disease and Treatment 2016, 12:2973-2980

Published Date: 15 November 2016

ADHD and Present Hedonism: time perspective as a potential diagnostic and therapeutic tool

Weissenberger S, Klicperova-Baker M, Zimbardo P, Schonova K, Akotia D, Kostal J, Goetz M, Raboch J, Ptacek R

Neuropsychiatric Disease and Treatment 2016, 12:2963-2971

Published Date: 16 November 2016

The occurrence and predictive factors of sleep paralysis in university students

Lišková M, Janečková D, Klůzová Kráčmarová L, Mladá K, Bušková J

Neuropsychiatric Disease and Treatment 2016, 12:2957-2962

Published Date: 14 November 2016

Altered spontaneous brain activity pattern in patients with high myopia using amplitude of low-frequency fluctuation: a resting-state fMRI study

Huang X, Zhou FQ, Hu YX, Xu XX, Zhou X, Zhong YL, Wang J, Wu XR

Neuropsychiatric Disease and Treatment 2016, 12:2949-2956

Published Date: 14 November 2016

Posttraumatic stress and depression in Yazidi refugees

Nasıroğlu S, Çeri V

Neuropsychiatric Disease and Treatment 2016, 12:2941-2948

Published Date: 14 November 2016

Sex differences in the course of schizophrenia across diverse regions of the world

Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM

Neuropsychiatric Disease and Treatment 2016, 12:2927-2939

Published Date: 14 November 2016

Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease

Rej S, Saleem M, Herrmann N, Stefatos A, Rau A, Lanctôt KL

Neuropsychiatric Disease and Treatment 2016, 12:2913-2920

Published Date: 10 November 2016

Increased miR-132 level is associated with visual memory dysfunction in patients with depression

Liu Y, Yang X, Zhao L, Zhang J, Li T, Ma X

Neuropsychiatric Disease and Treatment 2016, 12:2905-2911

Published Date: 9 November 2016

Post-stroke dyskinesias

Nakawah MO, Lai EC

Neuropsychiatric Disease and Treatment 2016, 12:2885-2893

Published Date: 7 November 2016

The NCAN gene: schizophrenia susceptibility and cognitive dysfunction

Wang P, Cai J, Ni J, Zhang J, Tang W, Zhang C

Neuropsychiatric Disease and Treatment 2016, 12:2875-2883

Published Date: 4 November 2016

Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies

Han Y, Chen J, Zou D, Zheng P, Li Q, Wang H, Li P, Zhou X, Zhang Y, Liu Y, Xie P

Neuropsychiatric Disease and Treatment 2016, 12:2859-2867

Published Date: 3 November 2016

Effects of multiple training modalities in patients with Alzheimer’s disease: a pilot study

Tai SY, Hsu CL, Huang SW, Ma TC, Hsieh WC, Yang YH

Neuropsychiatric Disease and Treatment 2016, 12:2843-2849

Published Date: 1 November 2016

Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia

Wang LJ, Lin PY, Lee Y, Huang YC, Hsu ST, Hung CF, Chen CK, Chen YC, Wang YL, Tsai MC

Neuropsychiatric Disease and Treatment 2016, 12:2819-2826

Published Date: 31 October 2016

Beliefs and perception about mental health issues: a meta-synthesis

Choudhry FR, Mani V, Ming LC, Khan TM

Neuropsychiatric Disease and Treatment 2016, 12:2807-2818

Published Date: 31 October 2016

Psychometric properties of the self-rating organization scale with adult samples

Takeda T, Tsuji Y, Ando M

Neuropsychiatric Disease and Treatment 2016, 12:2799-2806

Published Date: 31 October 2016

Production of inflammatory cytokines, cortisol, and Aβ1-40 in elderly oral cancer patients with postoperative delirium

Sun L, Jia P, Zhang J, Zhang X, Zhang Y, Jiang H, Jiang W, Guo Y

Neuropsychiatric Disease and Treatment 2016, 12:2789-2795

Published Date: 27 October 2016

Autoimmune encephalitis in psychiatric institutions: current perspectives

Bost C, Pascual O, Honnorat J

Neuropsychiatric Disease and Treatment 2016, 12:2775-2787

Published Date: 27 October 2016

Prevalence and related factors of psychological distress among cancer inpatients using routine Distress Thermometer and Chinese Health Questionnaire screening

Chiou YJ, Chiu NM, Wang LJ, Li SH, Lee CY, Wu MK, Chen CC, Wu YS, Lee Y

Neuropsychiatric Disease and Treatment 2016, 12:2765-2773

Published Date: 25 October 2016

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data

Solem CT, Shelbaya A, Wan Y, Deshpande CG, Alvir J, Pappadopulos E

Neuropsychiatric Disease and Treatment 2016, 12:2755-2764

Published Date: 25 October 2016

Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being

Anand E, Berggren L, Landry J, Tóth Á, Detke HC

Neuropsychiatric Disease and Treatment 2016, 12:2737-2743

Published Date: 25 October 2016

Alpha-synuclein in cutaneous small nerve fibers

Siepmann T, Illigens BM, Barlinn K

Neuropsychiatric Disease and Treatment 2016, 12:2731-2735

Published Date: 25 October 2016

Exercise is medicine for depression: even when the “pill” is small

Hallgren M, Vancampfort D, Stubbs B

Neuropsychiatric Disease and Treatment 2016, 12:2715-2721

Published Date: 25 October 2016

Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study

Holubova M, Prasko J, Ociskova M, Marackova M, Grambal A, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2677-2687

Published Date: 19 October 2016

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders

Prasko J, Grambal A, Kasalova P, Kamaradova D, Ociskova M, Holubova M, Vrbova K, Sigmundova Z, Latalova K, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:2659-2676

Published Date: 17 October 2016

Changes in behavior as side effects in methylphenidate treatment: review of the literature

Konrad-Bindl DS, Gresser U, Richartz BM

Neuropsychiatric Disease and Treatment 2016, 12:2635-2647

Published Date: 12 October 2016

Shortened questionnaires to assess anxiety and depression during in-hospital rehabilitation: clinical validation and cutoff scores

Bertolotti G, Moroni L, Burro R, Spanevello A, Pedretti RFE, Giorgetti G

Neuropsychiatric Disease and Treatment 2016, 12:2627-2633

Published Date: 12 October 2016

Physical activity and self-esteem: testing direct and indirect relationships associated with psychological and physical mechanisms

Zamani Sani SH, Fathirezaie Z, Brand S, Pühse U, Holsboer-Trachsler E, Gerber M, Talepasand S

Neuropsychiatric Disease and Treatment 2016, 12:2617-2625

Published Date: 12 October 2016

Managing drug-resistant epilepsy: challenges and solutions

Dalic L, Cook MJ

Neuropsychiatric Disease and Treatment 2016, 12:2605-2616

Published Date: 12 October 2016

Impact of aggression, depression, and anxiety levels on quality of life in epilepsy patients

Izci F, Fındıklı E, Camkurt MA, Tuncel D, Şahin M

Neuropsychiatric Disease and Treatment 2016, 12:2595-2603

Published Date: 13 October 2016

Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole

Peters-Strickland T, Pestreich L, Hatch A, Rohatagi S, Baker RA, Docherty JP, Markovtsova L, Raja P, Weiden PJ, Walling DP

Neuropsychiatric Disease and Treatment 2016, 12:2587-2594

Published Date: 11 October 2016

Restless leg syndrome in hospitalized psychiatric patients in Lebanon: a pilot study

Talih F, Ajaltouni J, Kobeissy F

Neuropsychiatric Disease and Treatment 2016, 12:2581-2586

Published Date: 11 October 2016

Evaluation of anxiety condition among type 1 and type 2 diabetic patients

Bulut A, Bulut A

Neuropsychiatric Disease and Treatment 2016, 12:2573-2579

Published Date: 11 October 2016

Vagus nerve stimulation balanced disrupted default-mode network and salience network in a postsurgical epileptic patient

Wang KL, Chai Q, Qiao H, Zhang JG, Liu TH, Meng FG

Neuropsychiatric Disease and Treatment 2016, 12:2561-2571

Published Date: 11 October 2016

Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder

Prasko J, Ociskova M, Grambal A, Sigmundova Z, Kasalova P, Marackova M, Holubova M, Vrbova K, Latalova K, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2539-2552

Published Date: 7 October 2016

Identifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder

Tsutsumi T, Sugawara H, Ito R, Asano M, Shimizu S, Ishigooka J, Nishimura K

Neuropsychiatric Disease and Treatment 2016, 12:2533-2538

Published Date: 5 October 2016

Impaired social cognition in anorexia nervosa patients

Hamatani S, Tomotake M, Takeda T, Kameoka N, Kawabata M, Kubo H, Tada Y, Tomioka Y, Watanabe S, Ohmori T

Neuropsychiatric Disease and Treatment 2016, 12:2527-2531

Published Date: 5 October 2016

Role of berberine in Alzheimer’s disease

Cai Z, Wang C, Yang W

Neuropsychiatric Disease and Treatment 2016, 12:2509-2520

Published Date: 3 October 2016

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV

Tomita T, Yasui-Furukori N, Sugawara N, Ogasawara K, Katagai K, Saito H, Sawada K, Takahashi I, Nakamura K

Neuropsychiatric Disease and Treatment 2016, 12:2503-2508

Published Date: 30 September 2016

Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study

Schettino C, Dato C, Capaldo G, Sampaolo S, Di Iorio G, Melone MA

Neuropsychiatric Disease and Treatment 2016, 12:2497-2502

Published Date: 29 September 2016

Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model

Zhang E, Li M, Zhao J, Dong Y, Yang X, Huang J

Neuropsychiatric Disease and Treatment 2016, 12:2481-2487

Published Date: 29 September 2016

Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel?

Hendaus MA, Jomha FA, Alhammadi AH

Neuropsychiatric Disease and Treatment 2016, 12:2473-2479

Published Date: 27 September 2016

A longitudinal, event-related potential pilot study of adult obsessive-compulsive disorder with 1-year follow-up

Yamamuro K, Okada K, Kishimoto N, Ota T, Iida J, Kishimoto T

Neuropsychiatric Disease and Treatment 2016, 12:2463-2471

Published Date: 26 September 2016

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders

Grambal A, Prasko J, Kamaradova D, Latalova K, Holubova M, Marackova M, Ociskova M, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2439-2448

Published Date: 22 September 2016

Mean platelet volume and red cell distribution width levels in initial evaluation of panic disorder

Asoglu M, Aslan M, Imre O, Kivrak Y, Akil O, Savik E, Buyukaslan H, Fedai U, Altındag A

Neuropsychiatric Disease and Treatment 2016, 12:2435-2438

Published Date: 22 September 2016

Delirium as a complication of the surgical intensive care

Horacek R, Krnacova B, Prasko J, Latalova K

Neuropsychiatric Disease and Treatment 2016, 12:2425-2434

Published Date: 22 September 2016

Increased frontal electroencephalogram theta amplitude in patients with anorexia nervosa compared to healthy controls

Hestad KA, Weider S, Nilsen KB, Indredavik MS, Sand T

Neuropsychiatric Disease and Treatment 2016, 12:2419-2423

Published Date: 21 September 2016

miR-370 mimic inhibits replication of Japanese encephalitis virus in glioblastoma cells

Li W, Cheng P, Nie S, Cui W

Neuropsychiatric Disease and Treatment 2016, 12:2411-2417

Published Date: 21 September 2016

Distinctive Rorschach profiles of young adults with schizophrenia and autism spectrum disorder

Kishimoto N, Yamamuro K, Iida J, Ota T, Tanaka S, Kyo M, Kimoto S, Kishimoto T

Neuropsychiatric Disease and Treatment 2016, 12:2403-2410

Published Date: 21 September 2016

Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review

Feng DD, Tang T, Lin XP, Yang ZY, Yang S, Xia ZA, Wang Y, Zheng P, Wang Y, Zhang CH

Neuropsychiatric Disease and Treatment 2016, 12:2387-2402

Published Date: 20 September 2016

Varenicline improves motor and cognitive symptoms in early Huntington’s disease

McGregor AL, Dysart J, Tingle MD, Russell BR, Kydd RR, Finucane G

Neuropsychiatric Disease and Treatment 2016, 12:2381-2386

Published Date: 19 September 2016

Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism

Musova Z, Hancarova M, Havlovicova M, Pourova R, Hrdlicka M, Kraus J, Trkova M, Stejskal D, Sedlacek Z

Neuropsychiatric Disease and Treatment 2016, 12:2367-2372

Published Date: 19 September 2016

Splitting, impulsivity, and intimate partnerships in young obese women seeking bariatric treatment

Zmolikova J, Pichlerova D, Bob P, Schückova D, Herlesova J, Weiss P

Neuropsychiatric Disease and Treatment 2016, 12:2343-2347

Published Date: 16 September 2016

The role of NMDAR antibody in the etiopathogenesis of schizophrenia

Timucin D, Ozdemir O, Parlak M

Neuropsychiatric Disease and Treatment 2016, 12:2327-2332

Published Date: 13 September 2016

Autistic traits in women with primary dysmenorrhea: a case–control study

Toy H, Hergüner A, Şimşek S, Hergüner S

Neuropsychiatric Disease and Treatment 2016, 12:2319-2325

Published Date: 12 September 2016

Alexithymia, impulsiveness, and psychopathology in nonsuicidal self-injured adolescents

Gatta M, Dal Santo F, Rago A, Spoto A, Battistella PA

Neuropsychiatric Disease and Treatment 2016, 12:2307-2317

Published Date: 12 September 2016

Prescription patterns of benzodiazepines in the Lebanese adult population: a cross-sectional study

Ramadan WH, El Khoury GM, Deeb ME, Sheikh-Taha M

Neuropsychiatric Disease and Treatment 2016, 12:2299-2305

Published Date: 6 September 2016

Insomnia in patients on hemodialysis for a short versus long duration

Tomita T, Yasui-Furukori N, Oka M, Shimizu T, Nagashima A, Mitsuhashi K, Saito H, Nakamura K

Neuropsychiatric Disease and Treatment 2016, 12:2293-2298

Published Date: 2 September 2016

The combined effect of sleep and time of day on emotion decoding from dynamic visual cues in older adults

Tsokanaki P, Moraitou D, Papantoniou G

Neuropsychiatric Disease and Treatment 2016, 12:2283-2291

Published Date: 1 September 2016

Children who screen positive for autism at 2.5 years and receive early intervention: a prospective naturalistic 2-year outcome study

Spjut Jansson B, Miniscalco C, Westerlund J, Kantzer AK, Fernell E, Gillberg C

Neuropsychiatric Disease and Treatment 2016, 12:2255-2263

Published Date: 1 September 2016

Construction of standardized Arabic questionnaires for screening neurological disorders (dementia, stroke, epilepsy, movement disorders, muscle and neuromuscular junction disorders)

El Tallawy HN, Farghaly WMA, Rageh TA, Saleh AO, Mestekawy TAH, Darwish MMM, Abd El Hamed MA, Ali AM, Mahmoud DM

Neuropsychiatric Disease and Treatment 2016, 12:2245-2253

Published Date: 30 August 2016

Psychological distress and coping in military cadre candidates

Nakkas C, Annen H, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:2237-2243

Published Date: 29 August 2016

Investigation on Internet addiction disorder in adolescents in Anhui, People’s Republic of China

Chen Y, Kang Y, Gong W, He L, Jin Y, Zhu X, Yao Y

Neuropsychiatric Disease and Treatment 2016, 12:2233-2236

Published Date: 29 August 2016

Association between sequence variations of the Mediterranean fever gene and the risk of migraine: a case–control study

Coşkun S, Varol S, Özdemir HH, Çelik SB, Balduz M, Camkurt MA, Çim A, Arslan D, Çevik MU

Neuropsychiatric Disease and Treatment 2016, 12:2225-2232

Published Date: 29 August 2016

Characteristics of binge eating disorder in relation to diagnostic criteria

Wilfley DE, Citrome L, Herman BK

Neuropsychiatric Disease and Treatment 2016, 12:2213-2223

Published Date: 29 August 2016

Late life bipolar disorder evolving into frontotemporal dementia mimic

Dols A, Krudop W, Möller C, Shulman K, Sajatovic M, Pijnenburg YAL

Neuropsychiatric Disease and Treatment 2016, 12:2207-2212

Published Date: 7 September 2016

Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer’s Disease Neuroimaging Initiative

Russo MJ, Cohen G, Chrem Mendez P, Campos J, Nahas FE, Surace EI, Vazquez S, Gustafson D, Guinjoan S, Allegri RF, Sevlever G

Neuropsychiatric Disease and Treatment 2016, 12:2199-2206

Published Date: 13 September 2016

Diffusion tensor imaging in the characterization of multiple system atrophy

Rulseh AM, Keller J, Rusz J, Syka M, Brozova H, Rusina R, Havrankova P, Zarubova K, Malikova H, Jech R, Vymazal J

Neuropsychiatric Disease and Treatment 2016, 12:2181-2187

Published Date: 26 August 2016

Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults

Nakato Y, Inoue T, Nakagawa S, Kitaichi Y, Kameyama R, Wakatsuki Y, Kitagawa K, Omiya Y, Kusumi I

Neuropsychiatric Disease and Treatment 2016, 12:2173-2179

Published Date: 25 August 2016

Olfactory functioning in early multiple sclerosis: Sniffin’ Sticks Test study

Batur Caglayan HZ, Irkec C, Nazliel B, Akyol Gurses A, Capraz I

Neuropsychiatric Disease and Treatment 2016, 12:2143-2147

Published Date: 26 August 2016

The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapy

Iosifescu DV, Neborsky RJ, Valuck RJ

Neuropsychiatric Disease and Treatment 2016, 12:2131-2142

Published Date: 25 August 2016

Brain tissue partial pressure of oxygen predicts the outcome of severe traumatic brain injury under mild hypothermia treatment

Sun H, Zheng M, Wang Y, Diao Y, Zhao W, Wei Z

Neuropsychiatric Disease and Treatment 2016, 12:2125-2129

Published Date: 24 August 2016

Disruptive mood dysregulation disorder: current insights

Baweja R, Mayes SD, Hameed U, Waxmonsky JG

Neuropsychiatric Disease and Treatment 2016, 12:2115-2124

Published Date: 24 August 2016

Mood disorders in the elderly: prevalence, functional impact, and management challenges

Valiengo LCL, Stella F, Forlenza OV

Neuropsychiatric Disease and Treatment 2016, 12:2105-2114

Published Date: 24 August 2016

Forensic reporting of a case of sexual abuse broadcast on periscope

Nasıroğlu S, Çimen İD

Neuropsychiatric Disease and Treatment 2016, 12:2073-2075

Published Date: 19 August 2016

Mental health care use in medically unexplained and explained physical symptoms: findings from a general population study

van Eck van der Sluijs JF, ten Have M, Rijnders CA, van Marwijk HWJ, de Graaf R, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2016, 12:2063-2072

Published Date: 16 August 2016

Mean platelet volume in bipolar disorder: the search for an ideal biomarker

Mert DG, Terzi H

Neuropsychiatric Disease and Treatment 2016, 12:2057-2062

Published Date: 16 August 2016

The interactive effects of ketamine and magnesium upon depressive-like pathology

Razmjou S, Litteljohn D, Rudyk C, Syed S, Clarke M, Pentz R, Dwyer Z, Hayley S

Neuropsychiatric Disease and Treatment 2016, 12:2049-2056

Published Date: 8 September 2016

Evaluation and follow-up of cognitive functions in patients with minor stroke and transient ischemic attack

Deniz Ç, Çelik Y, Özdemir Gültekin T, Baran GE, Deniz Ç, Asil T

Neuropsychiatric Disease and Treatment 2016, 12:2039-2048

Published Date: 16 August 2016

Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity

Ozcan ME, Ince B, Karadeli HH, Gedikbasi A, Asil T, Altinoz MA

Neuropsychiatric Disease and Treatment 2016, 12:2033-2038

Published Date: 16 August 2016

HIV- and AIDS-associated neurocognitive functioning in Zambia – a perspective based on differences between the genders

Kabuba N, Menon JA, Franklin Jr DR, Heaton RK, Hestad KA

Neuropsychiatric Disease and Treatment 2016, 12:2021-2028

Published Date: 11 August 2016

Microstructural changes of whole brain in patients with comitant strabismus: evidence from a diffusion tensor imaging study

Huang X, Li HJ, Zhang Y, Peng DC, Hu PH, Zhong YL, Zhou FQ, Shao Y

Neuropsychiatric Disease and Treatment 2016, 12:2007-2014

Published Date: 12 August 2016

Two-year prognosis after residential treatment for patients with alcohol dependence: three chief guidelines for sobriety in Japan

Cho T, Negoro H, Saka Y, Morikawa M, Kishimoto T

Neuropsychiatric Disease and Treatment 2016, 12:1983-1991

Published Date: 5 August 2016

Exercise is medicine for patients with major depressive disorders : but only if the “pill” is taken!

Gerber M, Holsboer-Trachsler E, Pühse U, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:1977-1981

Published Date: 5 August 2016

Brief behavioral treatment for patients with treatment-resistant insomnia

Wang J, Wei Q, Wu X, Zhong Z, Li G

Neuropsychiatric Disease and Treatment 2016, 12:1967-1975

Published Date: 4 August 2016

Stress, anxiety, and depression among parents of children with autism spectrum disorder in Oman: a case–control study

Al-Farsi OA, Al-Farsi YM, Al-Sharbati MM, Al-Adawi S

Neuropsychiatric Disease and Treatment 2016, 12:1943-1951

Published Date: 4 August 2016

Cycloid psychoses in the psychosis spectrum: evidence for biochemical differences with schizophrenia

van de Kerkhof NW, Fekkes D, van der Heijden FM, Hoogendijk WJ, Stöber G, Egger JI, Verhoeven WM

Neuropsychiatric Disease and Treatment 2016, 12:1927-1933

Published Date: 2 August 2016

Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis

Xiao J, Zhang J, Sun D, Wang L, Yu L, Wu H, Wang D, Qiu X

Neuropsychiatric Disease and Treatment 2016, 12:1919-1925

Published Date: 2 August 2016

Pain perception: predictive value of sex, depression, anxiety, somatosensory amplification, obesity, and age

Kivrak Y, Kose-Ozlece H, Ustundag MF, Asoglu M

Neuropsychiatric Disease and Treatment 2016, 12:1913-1918

Published Date: 1 August 2016

A study of patients with aggressive multiple sclerosis at disease onset

Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS

Neuropsychiatric Disease and Treatment 2016, 12:1907-1912

Published Date: 1 August 2016

Altered regional homogeneity in patients with unilateral acute open globe injury: a resting-state functional MRI study

Huang X, Li HJ, Ye L, Zhang Y, Wei R, Zhong YL, Peng DC, Shao Y

Neuropsychiatric Disease and Treatment 2016, 12:1901-1906

Published Date: 1 August 2016

Clinical characteristics of patients with benign nonlesional temporal lobe epilepsy

Kim J, Kim SH, Lim SC, Kim W, Shon YM

Neuropsychiatric Disease and Treatment 2016, 12:1887-1891

Published Date: 28 July 2016

Post-stroke emotional incontinence or bipolar disorder?

Mnif L, Sellami R, Masmoudi J

Neuropsychiatric Disease and Treatment 2016, 12:1883-1885

Published Date: 29 July 2016

Depression and pain: testing of serial multiple mediators

Wongpakaran T, Wongpakaran N, Tanchakvaranont S, Bookkamana P, Pinyopornpanish M, Wannarit K, Satthapisit S, Nakawiro D, Hiranyatheb T, Thongpibul K

Neuropsychiatric Disease and Treatment 2016, 12:1849-1860

Published Date: 25 July 2016

Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population

Morales-Marín ME, Genis-Mendoza AD, Tovilla-Zarate CA, Lanzagorta N, Escamilla M, Nicolini H

Neuropsychiatric Disease and Treatment 2016, 12:1843-1848

Published Date: 25 July 2016

Update on schizophrenia and bipolar disorder: focus on cariprazine

Roberts RJ, Findlay LJ, El-Mallakh PL, El-Mallakh RS

Neuropsychiatric Disease and Treatment 2016, 12:1837-1842

Published Date: 25 July 2016

Long-term administration of escitalopram in patients with social anxiety disorder in Japan

Asakura S, Hayano T, Hagino A, Koyama T

Neuropsychiatric Disease and Treatment 2016, 12:1817-1825

Published Date: 22 July 2016

Subgrouping of risky behaviors among Iranian college students: a latent class analysis

Safiri S, Rahimi-Movaghar A, Yunesian M, Sadeghi-Bazargani H, Shamsipour M, Mansournia MA, Fotouhi A

Neuropsychiatric Disease and Treatment 2016, 12:1809-1816

Published Date: 22 July 2016

The major risk factors for delirium in a clinical setting

Kim H, Chung S, Joo YH, Lee JS

Neuropsychiatric Disease and Treatment 2016, 12:1787-1793

Published Date: 21 July 2016

Association of brain-derived neurotrophic factor and nerve growth factor gene polymorphisms with susceptibility to migraine

Coskun S, Varol S, Ozdemir HH, Agacayak E, Aydın B, Kapan O, Camkurt MA, Tunc S, Cevik MU

Neuropsychiatric Disease and Treatment 2016, 12:1779-1785

Published Date: 19 July 2016

Zika virus challenges for neuropsychiatry

Simões e Silva AC, Moreira JM, Romanelli RMC, Teixeira AL

Neuropsychiatric Disease and Treatment 2016, 12:1747-1760

Published Date: 14 July 2016

ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan

Hatakenaka Y, Fernell E, Sakaguchi M, Ninomiya H, Fukunaga I, Gillberg C

Neuropsychiatric Disease and Treatment 2016, 12:1739-1746

Published Date: 14 July 2016

Involvement of upregulation of miR-210 in a rat epilepsy model

Chen L, Zheng H, Zhang S

Neuropsychiatric Disease and Treatment 2016, 12:1731-1737

Published Date: 13 July 2016

Evaluation of oxidant, antioxidant, and S100B levels in patients with conversion disorder

Büyükaslan H, Kandemir SB, Asoğlu M, Kaya H, Gökdemir MT, Karababa İF, Güngörmez F, Kılıçaslan F, Şavik E

Neuropsychiatric Disease and Treatment 2016, 12:1725-1729

Published Date: 13 July 2016

Cortical spreading depression produces a neuroprotective effect activating mitochondrial uncoupling protein-5

Viggiano E, Monda V, Messina A, Moscatelli F, Valenzano A, Tafuri D, Cibelli G, De Luca B, Messina G, Monda M

Neuropsychiatric Disease and Treatment 2016, 12:1705-1710

Published Date: 11 July 2016

A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts

Dell’Osso L, Del Grande C, Gesi C, Carmassi C, Musetti L

Neuropsychiatric Disease and Treatment 2016, 12:1687-1703

Published Date: 11 July 2016

Autism spectrum disorder in adults: diagnosis, management, and health services development

Murphy CM, Wilson CE, Robertson DM, Ecker C, Daly EM, Hammond N, Galanopoulos A, Dud I, Murphy DG, McAlonan GM

Neuropsychiatric Disease and Treatment 2016, 12:1669-1686

Published Date: 7 July 2016

Historical evolution of the concept of anorexia nervosa and relationships with orthorexia nervosa, autism, and obsessive-compulsive spectrum

Dell'Osso L, Abelli M, Carpita B, Pini S, Castellini G, Carmassi C, Ricca V

Neuropsychiatric Disease and Treatment 2016, 12:1651-1660

Published Date: 7 July 2016

Age at diagnosis of autism spectrum disorders: is there an association with socioeconomic status and family self-education about autism?

Hrdlicka M, Vacova M, Oslejskova H, Gondzova V, Vadlejchova I, Kocourkova J, Koutek J, Dudova I

Neuropsychiatric Disease and Treatment 2016, 12:1639-1644

Published Date: 6 July 2016

Risk-factor differences for nonsuicidal self-injury and suicide attempts in Mexican psychiatric patients

Fresán A, Camarena B, González-Castro TB, Tovilla-Zárate CA, Juárez-Rojop IE, López-Narváez L, González-Ramón AE, Hernández-Díaz Y

Neuropsychiatric Disease and Treatment 2016, 12:1631-1637

Published Date: 5 July 2016

5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients

Dong ZQ, Li XR, He L, He G, Yu T, Sun XL

Neuropsychiatric Disease and Treatment 2016, 12:1623-1629

Published Date: 4 July 2016

Effects of Astragalus polysaccharides on memory impairment in a diabetic rat model

Dun C, Liu J, Qiu F, Wu X, Wang Y, Zhao Y, Gu P

Neuropsychiatric Disease and Treatment 2016, 12:1617-1621

Published Date: 1 July 2016

Measuring illness insight in patients with alcohol-related cognitive dysfunction using the Q8 questionnaire: a validation study

Walvoort SJW, van der Heijden PT, Kessels RPC, Egger JIM

Neuropsychiatric Disease and Treatment 2016, 12:1609-1615

Published Date: 1 July 2016

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model

Tomaskova H, Kuhnova J, Cimler R, Dolezal O, Kuca K

Neuropsychiatric Disease and Treatment 2016, 12:1589-1598

Published Date: 30 June 2016

Parkinson's disease managing reversible neurodegeneration [Corrigendum]

Hinz M, Stein A, Cole T, McDougall B, Westaway M

Neuropsychiatric Disease and Treatment 2016, 12:1587-1588

Published Date: 28 June 2016

Cortisol awakening response in drug-naïve panic disorder

Jakuszkowiak-Wojten K, Landowski J, Wiglusz MS, Cubała WJ

Neuropsychiatric Disease and Treatment 2016, 12:1581-1585

Published Date: 27 June 2016

Mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adults

Sadeghi Bahmani D, Gerber M, Kalak N, Lemola S, Clough PJ, Calabrese P, Shaygannejad V, Pühse U, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:1571-1579

Published Date: 27 June 2016

Unmet needs of bipolar disorder patients

Hajda M, Prasko J, Latalova K, Hruby R, Ociskova M, Holubova M, Kamaradova D, Mainerova B

Neuropsychiatric Disease and Treatment 2016, 12:1561-1570

Published Date: 24 June 2016

Cognitive status in patients with multiple sclerosis in Lanzarote

Pérez-Martín MY, Eguia-del Rio P, González-Platas M, Jiménez-Sosa A

Neuropsychiatric Disease and Treatment 2016, 12:1553-1559

Published Date: 30 June 2016

Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients

Ociskova M, Prasko J, Latalova K, Kamaradova D, Grambal A

Neuropsychiatric Disease and Treatment 2016, 12:1539-1551

Published Date: 24 June 2016

Aggression in autism spectrum disorder: presentation and treatment options

Fitzpatrick SE, Srivorakiat L, Wink LK, Pedapati EV, Erickson CA

Neuropsychiatric Disease and Treatment 2016, 12:1525-1538

Published Date: 23 June 2016

Effect of adjuvant sleep hygiene psychoeducation and lorazepam on depression and sleep quality in patients with major depressive disorders: results from a randomized three-arm intervention

Rahimi A, Ahmadpanah M, Shamsaei F, Cheraghi F, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:1507-1515

Published Date: 22 June 2016

A door-to-door survey to estimate the prevalence of Parkinsonism in Pakistan

Khan S, Nabi G, Naeem M, Ali L, Silburn PA, Mellick GD

Neuropsychiatric Disease and Treatment 2016, 12:1499-1506

Published Date: 21 June 2016

Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study

Lana F, Sánchez-Gil C, Adroher ND, Pérez V, Feixas G, Martí-Bonany J, Torrens M

Neuropsychiatric Disease and Treatment 2016, 12:1477-1487

Published Date: 21 June 2016

Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies

Clayton AH, Durgam S, Tang X, Chen C, Ruth A, Gommoll C

Neuropsychiatric Disease and Treatment 2016, 12:1467-1476

Published Date: 21 June 2016

Psychometric properties of the Spanish version of the Clinical Outcomes in Routine Evaluation – Outcome Measure

Trujillo A, Feixas G, Bados A, García-Grau E, Salla M, Medina JC, Montesano A, Soriano J, Medeiros-Ferreira L, Cañete J, Corbella S, Grau A, Lana F, Evans C

Neuropsychiatric Disease and Treatment 2016, 12:1457-1466

Published Date: 21 June 2016

Altered lower leg muscle activation patterns in patients with cerebral palsy during cycling on an ergometer

Alves-Pinto A, Blumenstein T, Turova V, Lampe R

Neuropsychiatric Disease and Treatment 2016, 12:1445-1456

Published Date: 17 June 2016

The causes of new-onset epilepsy and seizures in the elderly

Liu S, Yu W, Lü Y

Neuropsychiatric Disease and Treatment 2016, 12:1425-1434

Published Date: 17 June 2016

Body integrity identity disorder crosses culture: case reports in the Japanese and Chinese literature

Blom RM, Vulink NC, van der Wal SJ, Nakamae T, Tan Z, Derks EM, Denys D

Neuropsychiatric Disease and Treatment 2016, 12:1419-1423

Published Date: 16 June 2016

Anterior cingulate hyperactivations during negative emotion processing among men with schizophrenia and a history of violent behavior

Tikàsz A, Potvin S, Lungu O, Joyal CC, Hodgins S, Mendrek A, Dumais A

Neuropsychiatric Disease and Treatment 2016, 12:1397-1410

Published Date: 15 June 2016

Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression

Zincir S, Öztürk P, Bilgen AE, İzci F, Yükselir C

Neuropsychiatric Disease and Treatment 2016, 12:1389-1396

Published Date: 15 June 2016

Early diagnosis and Early Start Denver Model intervention in autism spectrum disorders delivered in an Italian Public Health System service

Devescovi R, Monasta L, Mancini A, Bin M, Vellante V, Carrozzi M, Colombi C

Neuropsychiatric Disease and Treatment 2016, 12:1379-1384

Published Date: 14 June 2016

Abnormal spontaneous regional brain activity in primary insomnia: a resting-state functional magnetic resonance imaging study

Li C, Ma XF, Dong MS, Yin Y, Hua KL, Li M, Li CH, Zhan WF, Li C, Jiang GH

Neuropsychiatric Disease and Treatment 2016, 12:1371-1378

Published Date: 14 June 2016

The effect of ApoE e4 on blood pressure in patients with and without depression

Hestad KA, Engedal K, Whist JE, Farup PG

Neuropsychiatric Disease and Treatment 2016, 12:1365-1370

Published Date: 14 June 2016

Volumetric brain abnormalities in polysubstance use disorder patients

Noyan CO, Kose S, Nurmedov S, Metin B, Darcin AE, Dilbaz N

Neuropsychiatric Disease and Treatment 2016, 12:1355-1363

Published Date: 13 June 2016

Bilateral internal carotid artery dissection associated with prior syphilis: a case report and review of the literature

Marangi A, Moretto G, Cappellari M, Micheletti N, Tomelleri G, Bovi P

Neuropsychiatric Disease and Treatment 2016, 12:1351-1354

Published Date: 10 June 2016

Randomized controlled trials – a matter of design

Spieth PM, Kubasch AS, Penzlin AI, Illigens BM, Barlinn K, Siepmann T

Neuropsychiatric Disease and Treatment 2016, 12:1341-1349

Published Date: 10 June 2016

Investigating analgesic and psychological factors associated with risk of postpartum depression development: a case–control study

Suhitharan T, Pham TPT, Chen H, Assam PN, Sultana R, Han NLR, Tan EC, Sng BL

Neuropsychiatric Disease and Treatment 2016, 12:1333-1339

Published Date: 9 June 2016

Cognitive behavioral therapy for depression in Japanese Parkinson's disease patients: a pilot study

Shinmei I, Kobayashi K, Oe Y, Takagishi Y, Kanie A, Ito M, Takebayashi Y, Murata M, Horikoshi M, Dobkin RD

Neuropsychiatric Disease and Treatment 2016, 12:1319-1331

Published Date: 8 June 2016

The current state of physical activity and exercise programs in German-speaking, Swiss psychiatric hospitals: results from a brief online survey

Brand S, Colledge F, Beeler N, Pühse U, Kalak N, Sadeghi Bahmani D, Mikoteit T, Holsboer-Trachsler E, Gerber M

Neuropsychiatric Disease and Treatment 2016, 12:1309-1317

Published Date: 3 June 2016

Altered intrinsic regional brain spontaneous activity in patients with comitant strabismus: a resting-state functional MRI study

Huang X, Li SH, Zhou FQ, Zhang Y, Zhong YL, Cai FQ, Shao Y, Zeng XJ

Neuropsychiatric Disease and Treatment 2016, 12:1303-1308

Published Date: 3 June 2016

Chronic depression treated successfully with novel taping therapy: a new approach to the treatment of depression

Han CH, Hwang HS, Lee YJ, Lee SN, Abanes JJ, Lee BH

Neuropsychiatric Disease and Treatment 2016, 12:1281-1286

Published Date: 1 June 2016

Comparison of clinical features between primary and drug-induced sleep-related eating disorder

Komada Y, Takaesu Y, Matsui K, Nakamura M, Nishida S, Kanno M, Usui A, Inoue Y

Neuropsychiatric Disease and Treatment 2016, 12:1275-1280

Published Date: 26 May 2016

Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study

Beyazyüz M, Küfeciler T, Bulut L, Ünsal C, Albayrak Y, Akyol ES, Baykal S, Kuloglu M, Hashimoto K

Neuropsychiatric Disease and Treatment 2016, 12:1261-1268

Published Date: 23 May 2016

Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy

Tambucci R, Basti C, Maresca M, Coppola G, Verrotti A

Neuropsychiatric Disease and Treatment 2016, 12:1251-1260

Published Date: 23 May 2016

Low-dose aripiprazole for refractory burning mouth syndrome

Umezaki Y, Takenoshita M, Toyofuku A

Neuropsychiatric Disease and Treatment 2016, 12:1229-1231

Published Date: 19 May 2016

A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder

Craig F, Margari F, Legrottaglie AR, Palumbi R, de Giambattista C, Margari L

Neuropsychiatric Disease and Treatment 2016, 12:1191-1202

Published Date: 12 May 2016

Efficacy and motor complications of original and generic levodopa in Parkinson's disease treatment

Kasemsap N, Onsanit S, Chiewthanakul P, Kongbunkiat K, Tanking C, Vorasoot N, Sawanyawisuth K, Tiamkao S

Neuropsychiatric Disease and Treatment 2016, 12:1185-1189

Published Date: 11 May 2016

The role of psychiatrists in diagnosing conversion disorder: a mixed-methods analysis

Kanaan RA, Armstrong D, Wessely S

Neuropsychiatric Disease and Treatment 2016, 12:1181-1184

Published Date: 11 May 2016

Clinical usefulness of hemoencephalography beyond the neurofeedback

Serra-Sala M, Timoneda-Gallart C, Pérez-Álvarez F

Neuropsychiatric Disease and Treatment 2016, 12:1173-1180

Published Date: 11 May 2016

The impact of synapsin III gene on the neurometabolite level alterations after single-dose methylphenidate in attention-deficit hyperactivity disorder patients

Başay Ö, Kabukcu Basay B, Alacam H, Ozturk O, Buber A, Gorucu Yilmaz S, Kıroğlu Y, Erdal ME, Herken H

Neuropsychiatric Disease and Treatment 2016, 12:1141-1149

Published Date: 10 May 2016

The prevalence and risk factors of stroke in patients with chronic schizophrenia

Liang Y, Huang J, Tian J, Cao Y, Zhang G, Wang C, Cao Y, Li J

Neuropsychiatric Disease and Treatment 2016, 12:1131-1134

Published Date: 9 May 2016

Possible sertraline-induced extrapyramidal adverse effects in an adolescent

Wang LF, Huang JW, Shan SY, Ding JH, Lai JB, Xu Y, Hu SH

Neuropsychiatric Disease and Treatment 2016, 12:1127-1129

Published Date: 6 May 2016

Cognitive deficits in patients with obsessive–compulsive disorder – electroencephalography correlates

Kamaradova D, Hajda M, Prasko J, Taborsky J, Grambal A, Latalova K, Ociskova M, Brunovsky M, Hlustik P

Neuropsychiatric Disease and Treatment 2016, 12:1119-1125

Published Date: 6 May 2016

Spectrum of epilepsy – prevalence, impact, and treatment gap: an epidemiological study from Al-Quseir, Egypt

El-Tallawy HN, Farghaly WM, Rageh TA, Shehata GA, Metwally NA, Badry R, Sayed MA, Abdelwarith AM, Kandil MR, Hamed MA, Mohamed KO, Tohamy AM

Neuropsychiatric Disease and Treatment 2016, 12:1111-1118

Published Date: 12 May 2016

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review

Treuer T, Méndez L, Montgomery W, Wu S

Neuropsychiatric Disease and Treatment 2016, 12:1061-1083

Published Date: 3 May 2016

Risk factors for pneumonia among patients with Parkinson's disease: a Taiwan nationwide population-based study

Chang YP, Yang CJ, Hu KF, Chao AC, Chang YH, Hsieh KP, Tsai JH, Ho PS, Lim SY

Neuropsychiatric Disease and Treatment 2016, 12:1037-1046

Published Date: 27 April 2016

Anxiety and depression in patients with head and neck cancer: 6-month follow-up study

Wu YS, Lin PY, Chien CY, Fang FM, Chiu NM, Hung CF, Lee Y, Chong MY

Neuropsychiatric Disease and Treatment 2016, 12:1029-1036

Published Date: 27 April 2016

Investigation of PON1 activity and MDA levels in patients with epilepsy not receiving antiepileptic treatment

Dönmezdil N, Çevik MU, Özdemir HH, Taşin M

Neuropsychiatric Disease and Treatment 2016, 12:1013-1017

Published Date: 22 April 2016

Protective effects of L-glutamine against toxicity of deltamethrin in the cerebral tissue

Varol S, Özdemir HH, Çevik MU, Altun Y, Ibiloğlu I, Ekinci A, Ibiloğlu AO, Balduz M, Arslan D, Tekin R, Aktar F, Aluçlu MU

Neuropsychiatric Disease and Treatment 2016, 12:1005-1011

Published Date: 21 April 2016

Sense of alexithymia in patients with anxiety disorders comorbid with recurrent urticaria

Ogłodek EA, Szota AM, Just MJ, Araszkiewicz A, Szromek AR

Neuropsychiatric Disease and Treatment 2016, 12:995-1004

Published Date: 21 April 2016

The correlation between stress and economic crisis: a systematic review

Mucci N, Giorgi G, Roncaioli M, Fiz Perez J, Arcangeli G

Neuropsychiatric Disease and Treatment 2016, 12:983-993

Published Date: 21 April 2016

Diagnostic pitfalls in a young Romanian ranger with an acute psychotic episode

Nagy EE, Rácz A, Urbán E, Terhes G, Berki T, Horváth E, Georgescu AM, Zaharia-Kézdi IE

Neuropsychiatric Disease and Treatment 2016, 12:961-967

Published Date: 3 May 2016

Medication management during electroconvulsant therapy

Zolezzi M

Neuropsychiatric Disease and Treatment 2016, 12:931-939

Published Date: 19 April 2016

Olig1 expression pattern in neural cells during rat spinal cord development

Qi Q, Zhang Y, Shen L, Wang R, Zhou J, Lü H, Hu J

Neuropsychiatric Disease and Treatment 2016, 12:909-916

Published Date: 18 April 2016

Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia

Alosaimi FD, Alhabbad AA, Abalhassan MF, Fallata EO, Alzain NM, Alassiry MZ, Haddad BA

Neuropsychiatric Disease and Treatment 2016, 12:897-907

Published Date: 19 April 2016

Shen-Qi-Jie-Yu-Fang exerts effects on a rat model of postpartum depression by regulating inflammatory cytokines and CD4+CD25+ regulatory T cells

Li JY, Zhao RZ, Li XL, Sun WJ, Qu M, Tang QS, Yang XK, Zhang SJ

Neuropsychiatric Disease and Treatment 2016, 12:883-896

Published Date: 15 April 2016

Fear of falling: efficacy of virtual reality associated with serious games in elderly people

Levy F, Leboucher P, Rautureau G, Komano O, Millet B, Jouvent R

Neuropsychiatric Disease and Treatment 2016, 12:877-881

Published Date: 15 April 2016

Olfactory dysfunction in Alzheimer’s disease

Zou YM, Lu D, Liu LP, Zhang HH, Zhou YY

Neuropsychiatric Disease and Treatment 2016, 12:869-875

Published Date: 15 April 2016

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia

Urban-Kowalczyk M, Śmigielski J, Strzelecki D

Neuropsychiatric Disease and Treatment 2016, 12:863-868

Published Date: 15 April 2016

Altered intra- and interregional synchronization in relapsing–remitting multiple sclerosis: a resting-state fMRI study

Wu L, Zhang Y, Zhou F, Gao L, He L, Zeng X, Gong H

Neuropsychiatric Disease and Treatment 2016, 12:853-862

Published Date: 15 April 2016

Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder

Medhasi S, Pasomsub E, Vanwong N, Ngamsamut N, Puangpetch A, Chamnanphon M, Hongkaew Y, Limsila P, Pinthong D, Sukasem C

Neuropsychiatric Disease and Treatment 2016, 12:843-851

Published Date: 13 April 2016

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine

Guerdjikova AI, Mori N, Casuto LS, McElroy SL

Neuropsychiatric Disease and Treatment 2016, 12:833-841

Published Date: 18 April 2016

The influence of childhood abuse, adult life events, and affective temperaments on the well-being of the general, nonclinical adult population

Kanai Y, Takaesu Y, Nakai Y, Ichiki M, Sato M, Matsumoto Y, Ishikawa J, Ono Y, Murakoshi A, Tanabe H, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2016, 12:823-832

Published Date: 12 April 2016

Patients with depression display cytokine levels in serum and cerebrospinal fluid similar to patients with diffuse neurological symptoms without a defined diagnosis

Hestad KA, Engedal K, Whist JE, Aukrust P, Farup PG, Mollnes TE, Ueland T

Neuropsychiatric Disease and Treatment 2016, 12:817-822

Published Date: 13 April 2016

Relationship between quality of life and restless legs syndrome among a community-dwelling population in Japan

Kubo K, Sugawara N, Kaneda A, Takahashi I, Nakamura K, Nakaji S, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2016, 12:809-815

Published Date: 12 April 2016

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients

Novick D, Montgomery W, Aguado J, Peng XM, Haro JM

Neuropsychiatric Disease and Treatment 2016, 12:795-800

Published Date: 11 April 2016

Suicidal behavior and self-harm in girls with eating disorders

Koutek J, Kocourkova J, Dudova I

Neuropsychiatric Disease and Treatment 2016, 12:787-793

Published Date: 11 April 2016

Virtual reality for the treatment of posttraumatic disorders

Moraes TM, de Andrade AF, Paiva WS

Neuropsychiatric Disease and Treatment 2016, 12:785-786

Published Date: 7 April 2016

Does amantadine induce acute psychosis? A case report and literature review

Xu WJ, Wei N, Xu Y, Hu SH

Neuropsychiatric Disease and Treatment 2016, 12:781-783

Published Date: 6 April 2016

Positron emission tomography in patients with psychogenic non-epileptic seizures

McGonigal A, Arthuis M, Micoulaud-Franchi JA, Bartolomei F, Guedj E

Neuropsychiatric Disease and Treatment 2016, 12:777-778

Published Date: 5 April 2016

Parkinson’s disease managing reversible neurodegeneration

Hinz M, Stein A, Cole T, McDougall B, Westaway M

Neuropsychiatric Disease and Treatment 2016, 12:763-775

Published Date: 5 April 2016

A meta-synthesis on parenting a child with autism

Ooi KL, Ong YS, Jacob SA, Khan TM

Neuropsychiatric Disease and Treatment 2016, 12:745-762

Published Date: 5 April 2016

Demographic variables, clinical aspects, and medicolegal implications in a population of patients with adjustment disorder

Anastasia A, Colletti C, Cuoco V, Quartini A, Urso S, Rinaldi R, Bersani G

Neuropsychiatric Disease and Treatment 2016, 12:737-743

Published Date: 1 April 2016

Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review

Fornaro M, De Berardis D, Koshy AS, Perna G, Valchera A, Vancampfort D, Stubbs B

Neuropsychiatric Disease and Treatment 2016, 12:719-735

Published Date: 31 March 2016

Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report

Zhang B, Zhao Y, Liu J, Li L, Shan J, Zhao D, Yan C

Neuropsychiatric Disease and Treatment 2016, 12:713-717

Published Date: 29 March 2016

A family-oriented therapy program for youths with substance abuse: long-term outcomes related to relapse and academic or social status

Wang LJ, Lu SF, Chong MY, Chou WJ, Hsieh YL, Tsai TN, Chen C, Lee YH

Neuropsychiatric Disease and Treatment 2016, 12:699-706

Published Date: 30 March 2016

Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia

Cheng MF, Gu HY, Zheng LR, Wang HL, Zhong ZY, Wen SL

Neuropsychiatric Disease and Treatment 2016, 12:695-697

Published Date: 29 March 2016

Brain-derived neurotrophic factor modulates immune reaction in mice with peripheral nerve xenotransplantation

Yu X, Lu L, Liu Z, Yang T, Gong X, Ning Y, Jiang Y

Neuropsychiatric Disease and Treatment 2016, 12:685-694

Published Date: 29 March 2016

The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease

Yanartas O, Kani HT, Bicakci E, Kilic I, Banzragch M, Acikel C, Atug O, Kuscu K, Imeryuz N, Akin H

Neuropsychiatric Disease and Treatment 2016, 12:673-683

Published Date: 24 March 2016

Quality of life and parental styles assessed by adolescents suffering from inflammatory bowel diseases and their parents

Jelenova D, Prasko J, Ociskova M, Latalova K, Karaskova E, Hruby R, Kamaradova D, Mihal V

Neuropsychiatric Disease and Treatment 2016, 12:665-672

Published Date: 23 March 2016

Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function

Takeyoshi K, Kurita M, Nishino S, Teranishi M, Numata Y, Sato T, Okubo Y

Neuropsychiatric Disease and Treatment 2016, 12:641-649

Published Date: 15 March 2016

Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder

Vyskocilova J, Prasko J, Sipek J

Neuropsychiatric Disease and Treatment 2016, 12:625-639

Published Date: 14 March 2016

Effects of intracerebral hemorrhage on 5-hydroxymethylcytosine modification in mouse brains

Tang YL, Han S, Asakawa T, Luo YH, Han X, Xiao BG, Dong Q, Wang L

Neuropsychiatric Disease and Treatment 2016, 12:617-624

Published Date: 15 March 2016

No association between BDNFVal66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population

Umehara H, Numata S, Kinoshita M, Watanabe S, Nakaaki S, Sumitani S, Ohmori T

Neuropsychiatric Disease and Treatment 2016, 12:611-615

Published Date: 11 March 2016

Identification of a seasonal pattern to brain metastases

Sakellakis M, Koutras A, Pittaka M, Kardamakis D, Kalofonou M, Kalofonos HP, Spyropoulou D

Neuropsychiatric Disease and Treatment 2016, 12:609-610

Published Date: 7 March 2016

Validity and test–retest reliability of the Persian version of the Montgomery–Asberg Depression Rating Scale

Ahmadpanah M, Sheikhbabaei M, Haghighi M, Roham F, Jahangard L, Akhondi A, Sadeghi Bahmani D, Bajoghli H, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:603-607

Published Date: 7 March 2016

Occurrence of ADHD in parents of ADHD children in a clinical sample

Starck M, Grünwald J, Schlarb AA

Neuropsychiatric Disease and Treatment 2016, 12:581-588

Published Date: 3 March 2016

Attention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges faced

Ptacek R, Stefano GB, Weissenberger S, Akotia D, Raboch J, Papezova H, Domkarova L, Stepankova T, Goetz M

Neuropsychiatric Disease and Treatment 2016, 12:571-579

Published Date: 3 March 2016

Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study

Petrò E, Ruffini E, Cappuccio M, Guerini V, Belotti G, Fascendini S, Licini C, Marcassa C

Neuropsychiatric Disease and Treatment 2016, 12:559-569

Published Date: 2 March 2016

The noradrenergic paradox: implications in the management of depression and anxiety

Montoya A, Bruins R, Katzman MA, Blier P

Neuropsychiatric Disease and Treatment 2016, 12:541-557

Published Date: 1 March 2016

Assistive technologies for managing language disorders in dementia

Klimova B, Maresova P, Kuca K

Neuropsychiatric Disease and Treatment 2016, 12:533-540

Published Date: 29 February 2016

Association between sociodemographic characteristics and anxiety levels of violence-exposed patients admitted to emergency clinic

Hocagil H, Izci F, Hocagil AC, Findikli E, Korkmaz S, Koc MI

Neuropsychiatric Disease and Treatment 2016, 12:511-516

Published Date: 26 February 2016

Intelligence quotient discrepancy indicates levels of motor competence in preschool children at risk for developmental delays

Yu TY, Chen KL, Chou W, Yang SH, Kung SC, Lee YC, Tung LC

Neuropsychiatric Disease and Treatment 2016, 12:501-510

Published Date: 26 February 2016

Suvorexant: a promising, novel treatment for insomnia

Lee-Iannotti JK, Parish JM

Neuropsychiatric Disease and Treatment 2016, 12:491-495

Published Date: 25 February 2016

Medical management of epileptic seizures: challenges and solutions

Sarma AK, Khandker N, Kurczewski L, Brophy GM

Neuropsychiatric Disease and Treatment 2016, 12:467-485

Published Date: 24 February 2016

A voxel-based morphometric study of age- and sex-related changes in white matter volume in the normal aging brain

Liu H, Wang L, Geng Z, Zhu Q, Song Z, Chang R, Lv H

Neuropsychiatric Disease and Treatment 2016, 12:453-465

Published Date: 24 February 2016

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease

Guo YJ, Wang LN, Zhu MW, Zhang HH, Hu YZ, Han ZT, Liu J, Zhao WQ, Wang DX

Neuropsychiatric Disease and Treatment 2016, 12:445-452

Published Date: 26 February 2016

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan

Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Minami Y, Ozeki Y, Okamoto K, Sagae T, Someya T

Neuropsychiatric Disease and Treatment 2016, 12:427-436

Published Date: 24 February 2016

Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone

de Biase S, Valente M, Gigli GL

Neuropsychiatric Disease and Treatment 2016, 12:417-425

Published Date: 23 February 2016

The investigation of factors related to suicide attempts in Southeastern Turkey

Okan Ibiloglu A, Atli A, Demir S, Gunes M, Kaya MC, Bulut M, Sir A

Neuropsychiatric Disease and Treatment 2016, 12:407-416

Published Date: 23 February 2016

An Internet-based program for depression using activity and physiological sensors: efficacy, expectations, satisfaction, and ease of use

Botella C, Mira A, Moragrega I, García-Palacios A, Bretón-López J, Castilla D, Riera López del Amo A, Soler C, Molinari G, Quero S, Guillén-Botella V, Miralles I, Nebot S, Serrano B, Majoe D, Alcañiz M, Baños RM

Neuropsychiatric Disease and Treatment 2016, 12:393-406

Published Date: 23 February 2016

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

Novick D, Montgomery W, Haro JM, Moneta MV, Zhu G, Yue L, Hong J, Dueñas H, Brugnoli R

Neuropsychiatric Disease and Treatment 2016, 12:383-392

Published Date: 23 February 2016

DSM-5 PTSD and posttraumatic stress spectrum in Italian emergency personnel: correlations with work and social adjustment

Carmassi C, Gesi C, Simoncini M, Favilla L, Massimetti G, Olivieri MC, Conversano C, Santini M, Dell’Osso L

Neuropsychiatric Disease and Treatment 2016, 12:375-381

Published Date: 18 February 2016

Global economic burden of schizophrenia: a systematic review

Chong HY, Teoh SL, Wu DBC, Kotirum S, Chiou CF, Chaiyakunapruk N

Neuropsychiatric Disease and Treatment 2016, 12:357-373

Published Date: 16 February 2016

Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia

Kayhan F, Küçük A, Satan Y, İlgün E, Arslan S, İlik F

Neuropsychiatric Disease and Treatment 2016, 12:349-355

Published Date: 16 February 2016

Traumatic brain injury-induced sleep disorders

Viola-Saltzman M, Musleh C

Neuropsychiatric Disease and Treatment 2016, 12:339-348

Published Date: 15 February 2016

Preliminary report of improved sleep quality in patients with dry eye disease after initiation of topical therapy

Ayaki M, Toda I, Tachi N, Negishi K, Tsubota K

Neuropsychiatric Disease and Treatment 2016, 12:329-337

Published Date: 16 February 2016

Strategies to improve anxiety and depression in patients with COPD: a mental health perspective

Tselebis A, Pachi A, Ilias I, Kosmas E, Bratis D, Moussas G, Tzanakis N

Neuropsychiatric Disease and Treatment 2016, 12:297-328

Published Date: 9 February 2016

Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges

Williams AE, Giust JM, Kronenberger WG, Dunn DW

Neuropsychiatric Disease and Treatment 2016, 12:287-296

Published Date: 9 February 2016

Recruiting for research studies using online public advertisements examples from research in affective disorders

Wise T, Arnone D, Marwood L, Zahn R, Lythe KE, Young AH

Neuropsychiatric Disease and Treatment 2016, 12:279-285

Published Date: 5 February 2016

Chronic organophosphate-induced neuropsychiatric disorder: a case report

Ghimire SR, Parajuli S

Neuropsychiatric Disease and Treatment 2016, 12:275-277

Published Date: 4 February 2016

Depot-medication compliance for patients with psychotic disorders: the importance of illness insight and treatment motivation

Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Mulder CL

Neuropsychiatric Disease and Treatment 2016, 12:269-274

Published Date: 3 February 2016

Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis

Ueda S, Sakayori T, Omori A, Fukuta H, Kobayashi T, Ishizaka K, Saijo T, Okubo Y

Neuropsychiatric Disease and Treatment 2016, 12:265-268

Published Date: 2 February 2016

Electroencephalogram characteristics in patients with chronic fatigue syndrome

Wu T, Qi X, Su Y, Teng J, Xu X

Neuropsychiatric Disease and Treatment 2016, 12:241-249

Published Date: 28 January 2016

Mania following ketamine abuse

Lu YY, Lin CH, Lane HY

Neuropsychiatric Disease and Treatment 2016, 12:237-239

Published Date: 27 January 2016

Examining Dark Triad traits in relation to mental toughness and physical activity in young adults

Sabouri S, Gerber M, Sadeghi Bahmani D, Lemola S, Clough PJ, Kalak N, Shamsi M, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:229-235

Published Date: 27 January 2016

cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in rats

Liu X, Guo H, Sayed MDSOM, Lu Y, Yang T, Zhou D, Chen Z, Wang H, Wang C, Xu J

Neuropsychiatric Disease and Treatment 2016, 12:219-227

Published Date: 21 January 2016

A 5-year retrospective study of demographic, anamnestic, and clinical factors related to psychiatric hospitalizations of adolescent patients

Di Lorenzo R, Cimino N, Di Pietro E, Pollutri G, Neviani V, Ferri P

Neuropsychiatric Disease and Treatment 2016, 12:191-201

Published Date: 18 January 2016

Psychogenic nonepileptic seizures as a manifestation of psychological distress associated with undiagnosed autism spectrum disorder

Miyawaki D, Iwakura Y, Seto T, Kusaka H, Goto A, Okada Y, Asada N, Yanagihara E, Inoue K

Neuropsychiatric Disease and Treatment 2016, 12:185-189

Published Date: 18 January 2016

The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups

Gerez M, Suárez E, Serrano C, Castanedo L, Tello A

Neuropsychiatric Disease and Treatment 2016, 12:159-175

Published Date: 18 January 2016

Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt

El-Tallawy HN, Farghaly WM, Badry R, Metwally NA, Shehata GA, Rageh TA, El Hamed MA, Kandil MR

Neuropsychiatric Disease and Treatment 2016, 12:155-158

Published Date: 13 January 2016

Higher emotional intelligence is related to lower test anxiety among students

Ahmadpanah M, Keshavarz M, Haghighi M, Jahangard L, Bajoghli H, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:133-136

Published Date: 12 January 2016

Synesthetic associations and psychosensory symptoms of temporal epilepsy

Neckar M, Bob P

Neuropsychiatric Disease and Treatment 2016, 12:109-112

Published Date: 11 January 2016

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder

Harada E, Shirakawa O, Satoi Y, Marangell LB, Escobar R

Neuropsychiatric Disease and Treatment 2016, 12:89-97

Published Date: 11 January 2016

Optimal management of ADHD in older adults

Torgersen T, Gjervan B, Lensing MB, Rasmussen K

Neuropsychiatric Disease and Treatment 2016, 12:79-87

Published Date: 8 January 2016

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review

Karson C, Duffy RA, Eramo A, Nylander AG, Offord SJ

Neuropsychiatric Disease and Treatment 2016, 12:57-67

Published Date: 6 January 2016

Affective network and default mode network in depressive adolescents with disruptive behaviors

Kim SM, Park SY, Kim YI, Son YD, Chung US, Min KJ, Han DH

Neuropsychiatric Disease and Treatment 2016, 12:49-56

Published Date: 31 December 2015

Computer task performance by subjects with Duchenne muscular dystrophy

Malheiros SRP, da Silva TD, Favero FM, de Abreu LC, Fregni F, Ribeiro DC, de Mello Monteiro CB

Neuropsychiatric Disease and Treatment 2016, 12:41-48

Published Date: 30 December 2015

Influence of hypothyroidism on renal function of lithium-treated patients

Lozano R, Marín R, Santacruz MJ

Neuropsychiatric Disease and Treatment 2016, 12:25-27

Published Date: 23 December 2015